Our Research Publications
Updated August 2025
| Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
|---|---|---|---|---|---|---|
| Overcoming the deceptively low viability of CD45+ cells in thawed cord blood unit segments | Pasha R, Halpenny M, Pineault N | 2019 | Vox Sang | View Overcoming the deceptively low viability of CD45+ cells in thawed cord blood unit segments | Researchers | New or improved product or process |
| Paracrine Factors Released by Osteoblasts Provide Strong Platelet Engraftment Properties | Abu-Khader A, Law KW, Jahan S, Manesia JK, Pasha R, Hovey O, Pineault N | 2019 | Stem Cells | View Paracrine Factors Released by Osteoblasts Provide Strong Platelet Engraftment Properties | Researchers | Basic research |
| Alpha-Dystroglycan Supports Platelet Aggregation and Thrombus Formation | Wang Y, Gallant RC, Neves MAD, Lei X, Gupta S, Coelho R, Wong T, Cohn RD, Campbell KP, Ni H | 2019 | Blood | View Alpha-Dystroglycan Supports Platelet Aggregation and Thrombus Formation | Researchers | Basic research |
| Defining certainty of net benefit: a GRADE concept paper | Alper BS, Oettgen P, Kunnamo I, Iorio A, Ansari MT, Murad MH, Meerpohl JJ, Qaseem A, Hultcrantz M, Schunemann HJ, Guyatt G, GRADE Working Group | 2019 | BMJ Open | View Defining certainty of net benefit: a GRADE concept paper | Researchers | Clinical research |
| Human red blood cell stroma: an alternative to traditional allogeneic adsorption methods | Wilson EM, Branch DR | 2019 | Transfusion | View Human red blood cell stroma: an alternative to traditional allogeneic adsorption methods | Researchers | Basic research |
| Neutrophil and Monocyte Counts in Heparin-Induced Thrombocytopenia | Hui M, Sheppard JI, Li N, Warkentin TE | 2019 | Thromb Haemost | View Neutrophil and Monocyte Counts in Heparin-Induced Thrombocytopenia | Health care providers | Clinical research |
| Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients | Chelle P, Yeung CHT, Bonanad S, Morales Munoz JC, Ozelo MC, Megias Vericat JE, Iorio A, Spears J, Mir R, Edginton A | 2019 | J Pharmacokinet Pharmacodyn | View Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients | Health care providers | Clinical research |
| How we treat paroxysmal nocturnal hemoglobinuria: A consensus statement of the Canadian PNH Network and review of the national registry | Patriquin CJ, Kiss T, Caplan S, Chin-Yee I, Grewal K, Grossman J, Larratt L, Marceau D, Nevill T, Sutherland DR, Wells RA, Leber B | 2019 | Eur J Haematol | View How we treat paroxysmal nocturnal hemoglobinuria: A consensus statement of the Canadian PNH Network and review of the national registry | Researchers | Clinical research |
| Assessing the Threat: Public Concern | Wiles A, Bennett JL, Devine D | 2019 | Blood Safety : A Guide to Monitoring and Responding to Potential New Threats | View Assessing the Threat: Public Concern | Other | Benchmarking and standard setting |
| Evaluating the Clinical Effect of Female Blood Donors of Child-Bearing Age on Maternal and Neonatal Outcomes: A Cohort Study | Chassé M, Tinmouth A, Goldman M, O'Brien SF, Hawken S, Murphy MSQ, Walker M, Sprague AE, Wilson K, van Walraven C, Fergusson DA | 2019 | Transfus Med Rev | View Evaluating the Clinical Effect of Female Blood Donors of Child-Bearing Age on Maternal and Neonatal Outcomes: A Cohort Study | Researchers | Clinical research |
| Postnatal intervention for the treatment of FNAIT: a systematic review | Baker JM, Shehata N, Bussel J, Murphy MF, Greinacher A, Bakchoul T, Massey E, Lieberman L, Landry D, Tanael S, Arnold DM, Baidya S, Bertrand G, Kjaer M, Kaplan C, Kjeldsen-Kragh J, Oepkes D, Savoia H, Ryan G, Hume H, On behalf of the International Collaboration for Transfusion Medicine Guidelines (ICTMG) | 2019 | J Perinatol | View Postnatal intervention for the treatment of FNAIT: a systematic review | Health care providers | Clinical research |
| Système Lewis : les anticorps anti-Lewis | Peng S, Meunier D | 2019 | Blood.ca website | View Système Lewis : les anticorps anti-Lewis | Health care providers | Benchmarking and standard setting |
| Eluates from DAT-positive patients with or without hemolysis after high-dose IVIG yield predominantly IgG isoagglutinins of IgG2 subclass | Yung GP, Seebach JD, Baerenzung N, Pendergrast J, Cserti-Gazdewich C, Branch DR | 2019 | Transfusion | View Eluates from DAT-positive patients with or without hemolysis after high-dose IVIG yield predominantly IgG isoagglutinins of IgG2 subclass | Health care providers | Clinical research |
| Intravenous immunoglobulin (IVIg) or IVIg-treated macrophages reduce DSS-induced colitis by inducing macrophage IL-10 production | Kozicky LK, Menzies SC, Hotte N, Madsen KL, Sly LM | 2019 | Eur J Immunol | View Intravenous immunoglobulin (IVIg) or IVIg-treated macrophages reduce DSS-induced colitis by inducing macrophage IL-10 production | Researchers | Basic research |
| Platelet rich plasma in treatment of musculoskeletal pathologies | Mehrabani D, Seghatchian J, Acker JP | 2019 | Transfus Apher Sci | View Platelet rich plasma in treatment of musculoskeletal pathologies | Researchers | Basic research |
| Système Diego : l’anticorps anti-Dia | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Diego : l’anticorps anti-Dia | Health care providers | Benchmarking and standard setting |
| Changes in minimum hemoglobin and interdonation interval: impact on donor hemoglobin and donation frequency | Goldman M, Yi Q-L, Steed T, O'Brien SF | 2019 | Transfusion | View Changes in minimum hemoglobin and interdonation interval: impact on donor hemoglobin and donation frequency | Researchers | New or improved product or process |
| Transfusion-related acute lung injury (TRALI) | Petraszko T | 2019 | Blood.ca website | View Transfusion-related acute lung injury (TRALI) | Researchers | Clinical research |
| Virus envelope tissue factor promotes infection in mice | Sutherland MR, Simon AY, Shanina I, Horwitz MS, Ruf W, Pryzdial ELG | 2019 | J Thromb Haemost | View Virus envelope tissue factor promotes infection in mice | Researchers | Basic research |
| Safeguarding the Patient's Own Blood Supply | Zeller MP, Kaufman RM | 2019 | JAMA | View Safeguarding the Patient's Own Blood Supply | Health care providers | Clinical research |
| Concentré de recherche: Transfusion de culots globulaires?: lien entre la non-concordance des sexes et la mortalité | Zeller M | 2019 | Blood.ca website | View Concentré de recherche: Transfusion de culots globulaires?: lien entre la non-concordance des sexes et la mortalité | Health care providers | Clinical research |
| Model Human ? Thalassemic Erythrocytes: Effect of Unpaired Purified ?-Hemoglobin Chains on Normal Erythrocytes | Scott M | 2019 | Beta Thalassemia | View Model Human ? Thalassemic Erythrocytes: Effect of Unpaired Purified ?-Hemoglobin Chains on Normal Erythrocytes | Researchers | Basic research |
| The effect of tantalum incorporation on the physical and chemical properties of ternary silicon–calcium–phosphorous mesoporous bioactive glasses | Mendonca A, Rahman MS, Alhalawani A, Rodriguez O, Gallant RC, Ni H, Clarkin OM, Towler MR | 2019 | J Biomed Mater Res B Appl Biomater | View The effect of tantalum incorporation on the physical and chemical properties of ternary silicon–calcium–phosphorous mesoporous bioactive glasses | Researchers | Basic research |
| Trends and outcomes in multicomponent blood transfusion: an 11-year cohort study of a large multisite academic center | Perelman I, Saidenberg E, Tinmouth A, Fergusson D | 2019 | Transfusion | View Trends and outcomes in multicomponent blood transfusion: an 11-year cohort study of a large multisite academic center | Researchers | Clinical research |
| Comparative pharmacokinetics of two extended half-life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference? | Carcao MD, Chelle P, Clarke E, Kim L, Tiseo L, Morfini M, Hossain T, Rand ML, Brown C, Edginton AN, Lillicrap D, Iorio A, Blanchette VS | 2019 | J Thromb Haemost | View Comparative pharmacokinetics of two extended half-life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference? | Researchers | Clinical research |
| Fractionated blood products and associated pathogen safety | Bigham M | 2019 | Clinical Guide to Transfusion | View Fractionated blood products and associated pathogen safety | Health care providers | Benchmarking and standard setting |
| Major reductions in unnecessary aspartate aminotransferase and blood urea nitrogen tests with a quality improvement initiative | Strauss R, Cressman A, Cheung M, Weinerman A, Waldman S, Etchells E, Zahirieh A, Tartaro P, Tezmovitz J, Callum J | 2019 | BMJ Quality & Safety | View Major reductions in unnecessary aspartate aminotransferase and blood urea nitrogen tests with a quality improvement initiative | Health care providers | Clinical research |
| Rapport de surveillance 2018 | O'Brien S | 2019 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
| Transfusion Camp: a prospective evaluation of a transfusion education program for multispecialty postgraduate trainees | Lin Y, Tilokee E, Chargé S, Alam A, Cserti-Gazdewich C, Lau W, Lee C, Lieberman L, Nixon P, Owens W, Pavenski K, Pendergrast J, Saidenberg E, Shehata N, Skeate R, Yi Q-L, Conrad D, Dudebout J, Hsia CC, Murphy M, Prokopchuk-Gauk O, Shah A, Solh Z, Trudeau J, Zeller MP, Callum J | 2019 | Transfusion | View Transfusion Camp: a prospective evaluation of a transfusion education program for multispecialty postgraduate trainees | Health care providers | Other |
| Trombocitopenia alloimmune fetale e neonatale: Informazioni per il paziente | International Collaboration for Transfusion Medicine Guidelines | 2019 | ICTMG.org website | View Trombocitopenia alloimmune fetale e neonatale: Informazioni per il paziente | Other | Other |
| Concentré de recherche : Dépistage d'agents pathogènes : la modélisation du risque au service de la sécurité de l'approvisionnement en sang | O'Brien S | 2019 | Blood.ca website | View Concentré de recherche : Dépistage d'agents pathogènes : la modélisation du risque au service de la sécurité de l'approvisionnement en sang | Researchers | Basic research |
| Cross-linked hemoglobin bis-tetramers from bioorthogonal coupling do not induce vasoconstriction in the circulation | Wang A, Singh S, Yu B, Bloch DB, Zapol WM, Kluger R | 2019 | Transfusion | View Cross-linked hemoglobin bis-tetramers from bioorthogonal coupling do not induce vasoconstriction in the circulation | Researchers | Basic research |
| Bacterial survival in whole blood depends on plasma sensitivity and resistance to neutrophil killing | Taha M, Kyluik-Price D, Kumaran D, Scott MD, Toyofuku W, Ramirez-Arcos S | 2019 | Transfusion | View Bacterial survival in whole blood depends on plasma sensitivity and resistance to neutrophil killing | Researchers | Basic research |
| Diego System: Anti-Wra | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Diego System: Anti-Wra | Health care providers | Benchmarking and standard setting |
| Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant | Douketis JD, Spyropoulos AC, Duncan J, Carrier M, Le Gal G, Tafur AJ, Vanassche T, Verhamme P, Shivakumar S, Gross PL, Lee AYY, Yeo E, Solymoss S, Kassis J, Le Templier G, Kowalski S, Blostein M, Shah V, MacKay E, Wu C, Clark NP, Bates SM, Spencer FA, Arnaoutoglou E, Coppens M, Arnold DM, Caprini JA, Li N, Moffat KA, Syed S, Schulman S | 2019 | JAMA Intern Med | View Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant | Health care providers | Benchmarking and standard setting |
| American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease | Liem RI, Lanzkron S, T DC, DeCastro L, Desai AA, Ataga KI, Cohen RT, Haynes J, Osunkwo I, Lebensburger JD, Lash JP, Wun T, Verhovsek M, Ontala E, Blaylark R, Alahdab F, Katabi A, Mustafa RA | 2019 | Blood Adv | View American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease | Health care providers | Benchmarking and standard setting |
| Not all red cell concentrate units are equivalent: international survey of processing and in vitro quality data | Shih AW, Apelseth TO, Cardigan R, Marks DC, Bégué S, Greinacher A, de Korte D, Seltsam A, Shaz BH, Wikman A, Barty RL, Heddle NM, Acker JP, The QMiP Investigators on behalf of the Biomedical Excellence for Safer Transfusion Collaborative | 2019 | Vox Sang | View Not all red cell concentrate units are equivalent: international survey of processing and in vitro quality data | Researchers | Benchmarking and standard setting |
| Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Goldman M, Drews S, Devine D | 2019 | Guide de la pratique transfusionnelle | View Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Health care providers | Benchmarking and standard setting |
| The peptidoglycan and biofilm matrix of Staphylococcus epidermidis undergo structural changes when exposed to human platelets | Loza-Correa M, Ayala JA, Perelman I, Hubbard K, Kalab M, Yi Q-L, Taha M, de Pedro MA, Ramirez-Arcos S | 2019 | PLoS One | View The peptidoglycan and biofilm matrix of Staphylococcus epidermidis undergo structural changes when exposed to human platelets | Researchers | Basic research |
| Circular of information for the use of human blood components: Plasma Components | Jenkins C | 2019 | Blood.ca website | View Circular of information for the use of human blood components: Plasma Components | Health care providers | Benchmarking and standard setting |
| Kell System: Anti-Jsa | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Kell System: Anti-Jsa | Health care providers | Benchmarking and standard setting |
| Pour un bon équilibre : protection des données dan les travaux de recherche | Ward R | 2019 | Blood.ca website | View Pour un bon équilibre : protection des données dan les travaux de recherche | Health care providers | Other |
| Système Lutheran : l’anticorps anti-Lua | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Lutheran : l’anticorps anti-Lua | Health care providers | Benchmarking and standard setting |
| Acquired Thrombocytopenia | Warkentin TE, Mithoowani S, Arnold DM | 2019 | Concise Guide to Hematology | View Acquired Thrombocytopenia | Other | Other |
| Changing the deferral for men who have sex with men - an improved model to estimate HIV residual risk | Davison KL, Gregoire Y, Germain M, Custer B, O'Brien SF, Steele WR, Pillonel J, Seed CR | 2019 | Vox Sang | View Changing the deferral for men who have sex with men - an improved model to estimate HIV residual risk | Blood operators | New or improved product or process |
| Ironing out frequent blood donation | Devine DV | 2019 | Lancet Haematol | View Ironing out frequent blood donation | Researchers | New or improved product or process |
| Système Diego : l’anticorps anti-Wra | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Diego : l’anticorps anti-Wra | Health care providers | Benchmarking and standard setting |
| Biocompatibility and toxicity of novel iron chelator Starch-Deferoxamine (S-DFO) compared to zinc oxide nanoparticles to zebrafish embryo: An oxidative stress based apoptosis, physicochemical and neurological study profile | Nasrallah GK, Salem R, Da'as S, Al-Jamal OLA, Scott M, Mustafa I | 2019 | Neurotoxicol Teratol | View Biocompatibility and toxicity of novel iron chelator Starch-Deferoxamine (S-DFO) compared to zinc oxide nanoparticles to zebrafish embryo: An oxidative stress based apoptosis, physicochemical and neurological study profile | Researchers | Basic research |
| The AABB Donor History Questionnaire | O'Brien S, Carayiannis S | 2019 | Screening Blood Donors with the Donor History Questionnaire | View The AABB Donor History Questionnaire | Blood operators | Benchmarking and standard setting |
| Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients | Chelle P, Yeung CHT, Bonanad S, Morales Munoz JC, Ozelo MC, Megias Vericat JE, Iorio A, Spears J, Mir R, Edginton A | 2019 | J Pharmacokinet Pharmacodyn | View Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients | Health care providers | Clinical research |